About: Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on July 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована в липні 2008 (uk) مقالة علمية نشرت في يوليو 2008 (ar) scientific article published on July 2008 (en) artículu científicu espublizáu en xunetu de 2008 (ast)
publication date	wds:Q37097986-AEE78683-F976-41C2-960D-3DBFDC4A78F7
publication date	2008-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37097986-81583BB9-A85B-4FA6-AE7D-0DFE5B9BA0D5
language of work or name	English
cites work	wds:Q37097986-0256C460-F3CD-46B8-AD8D-B9F7351FC233 wds:Q37097986-0C870620-9AFC-4CCA-AFAB-CB022B53DEF2 wds:Q37097986-151241A5-381B-43CF-AB9B-CF37DEB22545 wds:Q37097986-2D368D67-9263-4250-BF7C-2616665C35D7 wds:Q37097986-2D6E9FF3-6888-477D-9EB7-F221924582B0 wds:Q37097986-341C8815-7C40-4210-A369-2610FF42463A wds:Q37097986-388737A9-891B-405B-B3DE-5B1221E6542C wds:Q37097986-3E2C063C-EFE5-4C4D-925D-3C75726E17C5 wds:Q37097986-40D3AC03-5F5E-47DB-A9FB-1CC54AF31CF0 wds:Q37097986-41B8BC33-DBD7-4027-838E-B82DB3D5E4BB wds:Q37097986-44DCECB8-3EED-4955-A755-8B444BE0AD3F wds:Q37097986-6205F38E-FF89-49C6-877F-B8CA3638969B wds:Q37097986-63247EAB-DB52-40DE-AACB-7E79F7670F13 wds:Q37097986-66650DC5-1368-44C7-8088-75DB47E07454 wds:Q37097986-67F0B40E-D021-4AAA-B047-7A67CC867B8D wds:Q37097986-6A36460E-EDAF-4BEC-889F-99964BC5E098 wds:Q37097986-73912EB1-7D09-4D8A-82F5-A6B94DD94C21 wds:Q37097986-777EDBCA-2CF6-4D85-A7AA-5419E06CFE04 wds:Q37097986-7B478D64-26E8-4F26-9495-9DE9433F644D wds:Q37097986-813637B4-F844-4F77-9582-D55B20046039 wds:Q37097986-8F17B4F3-5096-44F4-B11D-5B44E41D9C68 wds:Q37097986-93798D77-4118-4318-AA75-E8C99ADB448C wds:Q37097986-9AE7289B-7C04-4619-BA89-568056819021 wds:Q37097986-9D8AABBB-721A-45AA-9DD8-373DB3CAC58D wds:Q37097986-B2BEA706-18C4-421B-A4EC-CC29A065C055 wds:Q37097986-B6E28985-69E2-4C4F-90D9-20A0E338389A wds:Q37097986-B71198DA-2F17-4355-9086-277C79C057C4 wds:Q37097986-B98522DD-1EED-49E3-8988-D0CFB6705465 wds:Q37097986-C1E8BBCF-A2C1-4210-97AD-FE414E447D84 wds:Q37097986-C31D742E-EB0F-45F1-9A01-19B7C8F2B4DC wds:Q37097986-C389662B-E4E4-47B7-9E32-170B6BE67CD7 wds:Q37097986-C4E53F39-6FD5-417E-8028-E1E7B47E245C wds:Q37097986-D932F75E-A3EA-44C6-929C-113FCBE7B5C2 wds:Q37097986-EE6A0395-F7D4-4912-85E0-F64444C3D5A1 wds:Q37097986-FB26EE5E-96E7-4151-B84C-C5FE83CD074E
cites work	Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria Peripheral arterial disease detection, awareness, and treatment in primary care Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. Peripheral arterial disease--epidemiological aspects Hypoxic regulation of angiopoietin-2 expression in endothelial cells. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review Recommended standards for reports dealing with lower extremity ischemia: revised version Vascular endothelial growth factor: basic science and clinical progress Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation Tie receptors: new modulators of angiogenic and lymphangiogenic responses Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Peripheral artery disease, diabetes, and reduced lower extremity functioning Peripheral arterial disease VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay Is a simple biomarker for peripheral arterial disease on the horizon? Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1 Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis? Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate
author name string	wds:Q37097986-9E44BDCC-5A58-42EA-954B-D32FF8B088F4 wds:Q37097986-A7AD09CD-DD5C-4C90-AD3B-70F121DAFA11 wds:Q37097986-CDFFBF9C-063E-4331-BCA4-3FA61EF8AF3A wds:Q37097986-FC34AE5D-1166-42A5-8C52-6B3B59245F7A
author name string	Christopher D Kontos Brian D Duscha Clarence M Findley Robert G Mitchell
rdfs:label	Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software